BANF1 and neoplasm: Interestingly, a recent study has shown that mutation or low expression of BAF/PBAF genes including SMARCA2 and PBRM1 were associated with higher neoantigen burden and higher tumor infiltration of activated CD8 T-cells in NSCLC [4].